The importance of BTK in the pathogenesis of chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and other mature B-cell malignancies is well established [47–49], while there is less information about the role of BTK in ALL. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.